| 1 |
34400066 | How accurate is 68Gallium-prostate specific membrane antigen positron emission tomography / computed tomography (68Ga-PSMA PET/CT) on primary lymph node staging before radical prostatectomy in intermediate and high risk prostate cancer? A study of patient- and lymph node- based analyses. | 2022 Jan |
1 |
| 2 |
34648046 | Ga-68 PSMA PET/CT in recurrent high-grade gliomas: evaluating PSMA expression in vivo. | 2022 May |
3 |
| 3 |
35189154 | Timing of Ga68-PSMA PETCT and patterns of recurrence after prostate radiotherapy: Implications for potential salvage. | 2022 Apr |
4 |
| 4 |
35220244 | Should 68Ga-PSMA PET/CT Replace CT and Bone Scan in Clinical Staging of High-risk Prostate Cancer? | 2022 Mar |
2 |
| 5 |
35397091 | The role of Ga68 PSMA PET/CT imaging in Lu177 PSMA treatment planning in metastatic castration-resistant prostate cancer. | 2022 Jun |
2 |
| 6 |
35503559 | A case of 68Ga-PSMA PET early dynamic image revealing occult recurrent lesion in the posterior wall of the urinary bladder. | 2022 Jan-Apr |
2 |
| 7 |
35543633 | Bone Uptake in Prostate Cancer Patients: Diagnostic Performances of PSMA-RADS v1.0, Clinical, Biological, and 68Ga-PSMA-11 PET Features to Predict Metastasis After Biochemical Recurrence. | 2022 May 11 |
2 |
| 8 |
31227464 | Positron Emission Tomography/Computed Tomography with Gallium-68-labeled Prostate-specific Membrane Antigen Detects Relapse After Vascular-targeted Photodynamic Therapy in a Prostate Cancer Model. | 2021 Mar |
3 |
| 9 |
32755196 | Diagnostic Accuracy of 68Ga-PSMA PET/CT for Initial Detection in Patients With Suspected Prostate Cancer: A Systematic Review and Meta-Analysis. | 2021 Mar |
2 |
| 10 |
32826958 | Diagnostic ability of Ga-68 PSMA PET to detect dominant and non-dominant tumors, upgrading and adverse pathology in patients with PIRADS 4-5 index lesions undergoing radical prostatectomy. | 2021 Mar |
3 |
| 11 |
33001304 | Differentiating benign and malignant pancreatic masses: Ga-68 PSMA PET/CT as a new diagnostic avenue. | 2021 Apr |
1 |
| 12 |
33223371 | Primary lymph-node staging with 68Ga-PSMA PET in high-risk prostate cancer: pathologic correlation with extended pelvic lymphadenectomy specimens. | 2021 Aug |
1 |
| 13 |
33402554 | Perineum and penile invasion of recurrent prostate carcinoma shown by Ga-68 PSMA PET/CT. | 2021 Jan-Mar |
2 |
| 14 |
33586413 | 68Ga PSMA Uptake at Roux-en-Y Eso-jejunostomy Junction Mimicking the Recurrence of Gastric Carcinoma in PET/CT. | 2021 Feb 9 |
2 |
| 15 |
33760944 | Antihormone treatment differentially regulates PSA secretion, PSMA expression and 68Ga-PSMA uptake in LNCaP cells. | 2021 Jun |
1 |
| 16 |
33782312 | Spurious Uptake on 68Ga-Prostate-Specific Membrane Antigen PET/CT Due to Ankylosing Spondylitis; A Rare Pitfall in Imaging of Biochemical Recurrence of Prostate Cancer. | 2021 Jul 1 |
1 |
| 17 |
33826565 | 68Ga-PSMA PET/CT Scan on Postoperative Assessment of Sinonasal Glomangiopericytoma. | 2021 Sep 1 |
1 |
| 18 |
33866336 | Role of 68Ga-PSMA PET/CT parameters in treatment evaluation and survival prediction in prostate cancer patients compared with biochemical response assessment. | 2021 Jan-Apr |
1 |
| 19 |
33866340 | Correlations of 68Ga-PSMA PET/CT in the initial staging of prostate cancer patients. | 2021 Jan-Apr |
1 |
| 20 |
33906800 | PSMA Theranostics: A "Must Have" in Every Prostate Cancer Center. Illustration of Two Clinical Cases and Review of the Literature. | 2021 Aug |
1 |
| 21 |
33912515 | The role of 68Gallium-prostate-specific membrane antigen positron emission tomography on staging of high-risk localized prostate cancer: for all high-risk patients or would it be better to select them? | 2021 Mar |
1 |
| 22 |
34040312 | Obstructive Jaundice: An Unusual Presentation of Neuroendocrine Differentiation in Prostatic Adenocarcinoma. | 2021 Jan-Mar |
3 |
| 23 |
34091649 | Thyroid Cancer Detected on 68Ga-PMSA PET/CT. | 2021 May |
1 |
| 24 |
34108764 | 68Ga-PSMA PET/CT: effect of external cooling on salivary gland uptake. | 2021 May-Jun |
1 |
| 25 |
34132237 | The value of intravenous contrast medium in PSMA PET/CT imaging in patients with biochemical recurrence of prostate cancer. | 2021 Nov 1 |
1 |
| 26 |
34208531 | Evaluation of Quantitative Ga-68 PSMA PET/CT Repeatability of Recurrent Prostate Cancer Lesions Using Both OSEM and Bayesian Penalized Likelihood Reconstruction Algorithms. | 2021 Jun 16 |
2 |
| 27 |
34268257 | The Role of Ga-68-PSMA PET/CT in the Initial Staging of Prostate Cancer - A Single Center 4 Year Experience. | 2021 |
1 |
| 28 |
34340959 | 68Ga-PSMA uptake in a radioiodine-refractory metastatic differentiated thyroid cancer patient. | 2021 Jul 30 |
1 |
| 29 |
34386454 | Performance of Ga-68 PSMA PET/CT for diagnosis and grading of local prostate cancer. | 2021 Jun |
1 |
| 30 |
34392297 | Haralick texture features extracted from Ga-68 PSMA PET/CT to differentiate normal prostate from prostate cancer: a feasibility study. | 2021 Dec 1 |
1 |
| 31 |
34522280 | Incidental prostate-specific membrane antigen-avid meningioma detected on 68Ga-prostate-specific membrane antigen PET/CT. | 2021 Nov |
1 |
| 32 |
34658229 | Is SUV Corrected for Lean Body Mass Superior to SUV of Body Weight in 68Ga-PSMA PET/CT? | 2021 Oct 15 |
1 |
| 33 |
34674367 | The Triple-Tracer strategy against Metastatic PrOstate cancer (3TMPO) study protocol. | 2021 Oct 21 |
1 |
| 34 |
34783763 | Tc-99m PSMA and Lu-177 PSMA Theranostic Pair in a Patient of Metastatic Castration Resistant Prostate Cancer. | 2021 Nov |
4 |
| 35 |
29745629 | Predictor of 68Ga PSMA PET/CT positivity in patients with prostate cancer. | 2020 Jun |
2 |
| 36 |
31885207 | Utility of Ga68 prostate-specific membrane antigen positron-emission tomography for pre-operative staging of high-risk prostate cancer in a prospective cohort. | 2020 Feb |
1 |
| 37 |
32064552 | Exploratory cost-effectiveness analysis of 68Gallium-PSMA PET/MRI-based imaging in patients with biochemical recurrence of prostate cancer. | 2020 Apr |
2 |
| 38 |
32281092 | Diagnostic Utility of Lutetium-177 (Lu 177) Prostate-Specific Membrane Antigen (PSMA) Scintigraphy In Prostate Cancer Patients With PSA Rise And Negative Conventional Imaging. | 2020 Jun 23 |
1 |
| 39 |
32303599 | Factors Predicting Metastatic Disease in 68Ga-PSMA-11 PET-Positive Osseous Lesions in Prostate Cancer. | 2020 Dec |
1 |
| 40 |
32351261 | Incremental Value of Ga-68 Prostate-Specific Membrane Antigen-11 Positron-Emission Tomography/Computed Tomography Scan for Preoperative Risk Stratification of Prostate Cancer. | 2020 Apr-Jun |
3 |
| 41 |
32481743 | The Value of 68Ga-PSMA PET/CT Following Equivocal 18F-NaF PET/CT in Prostate Cancer Patients. | 2020 May 28 |
1 |
| 42 |
32708097 | Diagnostic Performance of [18F]Fluorocholine and [68Ga]Ga-PSMA PET/CT in Prostate Cancer: A Comparative Study. | 2020 Jul 21 |
1 |
| 43 |
32796488 | Enhancing capacity and synthesis of [68Ga]68-Ga-PSMA-HBED-CC with the lyophilized ready-to-use kit for nuclear pharmacy applications. | 2020 Sep |
3 |
| 44 |
32842599 | Machine Learning Facilitates Hotspot Classification in PSMA-PET/CT with Nuclear Medicine Specialist Accuracy. | 2020 Aug 22 |
1 |
| 45 |
32941400 | Pilot study comparing dominant intraprostatic lesion volume using Ga-68 prostate-specific membrane antigen PET-computed tomography and multiparametric MRI. | 2020 Dec |
1 |
| 46 |
32969906 | Avid 68Ga-PSMA Uptake in Periappendicular Abscess. | 2020 Nov |
1 |
| 47 |
33082634 | Localization and restaging of carcinoma prostate by 68Gallium prostate-specific membrane antigen positron emission tomography computed tomography in patients with biochemical recurrence. | 2020 Jul-Sep |
1 |
| 48 |
33094572 | The Role of Ga-68 PSMA PET/CT Scan on Differentiating of Oligometastatic and High Risk Prostate Cancer | 2020 Oct 19 |
3 |
| 49 |
33175360 | Current status of radioligand therapy and positron-emission tomography with prostate-specific membrane antigen. | 2020 Dec |
2 |
| 50 |
33194309 | Combined Intravenous Urogram and 68Ga-PSMA PET/ CT for Improved Staging and Restaging of Prostate Cancer. | 2020 |
2 |